Drug Information

Drug General Information
Drug ID
D09PNQ
Former ID
DNC008424
Drug Name
2,3-dihydroxypropanal
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529225]
Formula
C3H6O3
Canonical SMILES
C(C(C=O)O)O
InChI
1S/C3H6O3/c4-1-3(6)2-5/h1,3,5-6H,2H2
InChIKey
MNQZXJOMYWMBOU-UHFFFAOYSA-N
PubChem Compound ID
751
Target and Pathway
Target(s) Aldose reductase Target Info Inhibitor [529225]
BioCyc Pathway Methylglyoxal degradation III
Acetone degradation I (to methylglyoxal)
KEGG Pathway Pentose and glucuronate interconversions
Fructose and mannose metabolism
Galactose metabolism
Glycerolipid metabolism
Metabolic pathways
NetPath Pathway IL1 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
PathWhiz Pathway Fructose and Mannose Degradation
Pyruvate Metabolism
Pterine Biosynthesis
Glycerolipid Metabolism
Galactose Metabolism
WikiPathways Metapathway biotransformation
Polyol Pathway
Metabolism of steroid hormones and vitamin D
References
Ref 529225Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20764-9. Epub 2007 Dec 17.Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10.
Ref 529225Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20764-9. Epub 2007 Dec 17.Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.